Wu, Y.; Tu, G.; Yuan, Y.; Liu, J.; Jiang, Q.; Liu, Y.; Wu, Q.; Wu, L.; Chen, Y.
The Molecular Chaperone TCP1 Affects Carcinogenicity and Is a Potential Therapeutic Target for Acute Myeloid Leukemia. Pharmaceutics 2025, 17, 557.
https://doi.org/10.3390/pharmaceutics17050557
AMA Style
Wu Y, Tu G, Yuan Y, Liu J, Jiang Q, Liu Y, Wu Q, Wu L, Chen Y.
The Molecular Chaperone TCP1 Affects Carcinogenicity and Is a Potential Therapeutic Target for Acute Myeloid Leukemia. Pharmaceutics. 2025; 17(5):557.
https://doi.org/10.3390/pharmaceutics17050557
Chicago/Turabian Style
Wu, Yong, Guihui Tu, Yuxia Yuan, Jingwen Liu, Qingna Jiang, Yang Liu, Qiurong Wu, Lixian Wu, and Yuanzhong Chen.
2025. "The Molecular Chaperone TCP1 Affects Carcinogenicity and Is a Potential Therapeutic Target for Acute Myeloid Leukemia" Pharmaceutics 17, no. 5: 557.
https://doi.org/10.3390/pharmaceutics17050557
APA Style
Wu, Y., Tu, G., Yuan, Y., Liu, J., Jiang, Q., Liu, Y., Wu, Q., Wu, L., & Chen, Y.
(2025). The Molecular Chaperone TCP1 Affects Carcinogenicity and Is a Potential Therapeutic Target for Acute Myeloid Leukemia. Pharmaceutics, 17(5), 557.
https://doi.org/10.3390/pharmaceutics17050557